Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, United States; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, United States.
Adv Cancer Res. 2023;160:1-15. doi: 10.1016/bs.acr.2023.03.001. Epub 2023 Mar 30.
Phosphofructokinase (PFK) is one of the key enzymes that functions in glycolysis. Studies show that PFKP regulates cell proliferation, apoptosis, autophagy, cell migration/metastasis, and stemness through glycolysis and glycolysis-independent functions. PFKP performs its function not only in the cytoplasm, but also at the cell membrane, on the mitochondria, at the lysosomal membrane, and in the nucleus. The functions of PFKP are extensively studied in cancer cells. PFKP is also highly expressed in certain immune cells; nevertheless, the study of the PFKP's role in immune cells is limited. In this review, we summarize how the expression and activity of PFKP are regulated in cancer cells. PFKP may be applied as a prognostic marker due to its overexpression and significant functions in cancer cells. As such, specifically targeting/inhibiting PFKP may be a critical and promising strategy for cancer therapy.
磷酸果糖激酶(PFK)是糖酵解过程中的关键酶之一。研究表明,PFKP 通过糖酵解和糖酵解非依赖性功能调节细胞增殖、凋亡、自噬、细胞迁移/转移和干性。PFKP 的功能不仅在细胞质中发挥,而且在细胞膜、线粒体、溶酶体膜和核内发挥。PFKP 在癌细胞中的功能得到了广泛研究。PFKP 在某些免疫细胞中也高度表达;然而,PFKP 在免疫细胞中的作用研究有限。在这篇综述中,我们总结了 PFKP 在癌细胞中的表达和活性是如何被调节的。由于其在癌细胞中的过表达和重要功能,PFKP 可能被用作预后标志物。因此,特异性靶向/抑制 PFKP 可能是癌症治疗的一个关键和有前途的策略。